Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activity
Year: 2020
Type: article
Source: Leukemia
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G6493640606
OpenAlex ID: W3000933100
